Compare · BDX vs LMNX
BDX vs LMNX
Side-by-side comparison of Becton Dickinson and Company (BDX) and Luminex Corporation (LMNX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDX and LMNX operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BDX carries a market cap of $72.89B.
- Over the past year, BDX is down 25.7% and LMNX is up 13.3% - LMNX leads by 39.0 points.
- BDX has hit the wire 9 times in the past 4 weeks while LMNX has been quiet.
- BDX has more recent analyst coverage (25 ratings vs 0 for LMNX).
- Company
- Becton Dickinson and Company
- Luminex Corporation
- Price
- $152.11-1.77%
- $19.04-1.45%
- Market cap
- $72.89B
- -
- 1M return
- -3.89%
- -10.23%
- 1Y return
- -25.68%
- +13.33%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2000
- News (4w)
- 9
- 0
- Recent ratings
- 25
- 0
Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Latest BDX
- BD Earns Industry Top Honors for Transparency, Resiliency and Partnership
- Goldman resumed coverage on Becton Dickinson with a new price target
- Becton Dickinson and Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- BD to Announce Financial Results for its Second Quarter of Fiscal 2026
- Rick Byrd to Retire from BD
- For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System
- BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
- When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight
- SEC Form 4 filed by Neal Shana Carol
- Becton Dickinson and Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest LMNX
- SEC Form 15-12G filed by Luminex Corporation
- SEC Form 4: Eck Stephen L. returned $1,408,701 worth of Common Stock to the company (38,073 units at $37.00) , closing all direct ownership in the company (for withholding tax)
- SEC Form 4: ERICKSON THOMAS W returned $6,932,542 worth of Common Stock to the company (187,366 units at $37.00) , closing all direct ownership in the company to cover taxes
- SEC Form 4: KEVER JIM D returned $8,517,363 worth of Common Stock to the company (230,199 units at $37.00) , closing all direct ownership in the company to satisfy withholding obligation
- SEC Form 4: Lewis Dijuana K returned $257,335 worth of Common Stock to the company (6,955 units at $37.00) , closing all direct ownership in the company
- SEC Form 4: MCNAMARA KEVIN M returned $3,713,616 worth of Common Stock to the company (100,368 units at $37.00) , closing all direct ownership in the company to cover withholding tax
- SEC Form 4: OGUNRO EDWARD A returned $2,253,041 worth of Common Stock to the company (60,893 units at $37.00) , closing all direct ownership in the company to cover taxes
- SEC Form 4: SAMET KENNETH A returned $733,229 worth of Common Stock to the company (19,817 units at $37.00) , closing all direct ownership in the company (withholding tax)
- SEC Form 4: Rew Richard W. II returned $1,760,312 worth of Common Stock to the company (47,576 units at $37.00) , closing all direct ownership in the company to satisfy withholding tax
- SEC Form 4: SHAMIR NACHUM returned $8,923,290 worth of Common Stock to the company (241,170 units at $37.00) , closing all direct ownership in the company to cover taxes